Thermo Fisher Scientific announces expiration of HSR waiting period for Dionex acquisition

Editorial Checklist Reviewed

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relating to its offer to acquire Dionex (NASDAQ: DNEX).

The company is in the process of seeking similar clearances under antitrust laws of other jurisdictions, and anticipates completing the acquisition later in the first quarter of 2011.

Source:

Thermo Fisher Scientific

Posted in: Life Sciences News

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Thermo Fisher Scientific launches industry-leading, cGMP-compatible CTS Series Laboratory Equipment